Distinctive metabolic profiles between Cystic Fibrosis mutational subclasses and lung function
- 4 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Metabolomics
- Vol. 17 (1), 1-19
- https://doi.org/10.1007/s11306-020-01760-5
Abstract
Introduction Cystic fibrosis (CF) is a lethal multisystemic disease of a monogenic origin with numerous mutations. Functional defects in the cystic fibrosis transmembrane conductance receptor (CFTR) protein based on these mutations are categorised into distinct classes having different clinical presentations and disease severity. Objectives The present study aimed to create a comprehensive metabolomic profile of altered metabolites in patients with CF, among different classes and in relation to lung function. Methods A chemical isotope labeling liquid chromatography-mass spectrometry metabolomics was used to study the serum metabolic profiles of young and adult CF (n = 39) patients and healthy controls (n = 30). Comparisons were made at three levels, CF vs. controls, among mutational classes of CF, between CF class III and IV, and correlated the lung function findings. Results A distinctive metabolic profile was observed in the three analyses. 78, 20, and 13 significantly differentially dysregulated metabolites were identified in the patients with CF, among the different classes and between class III and IV, respectively. The significantly identified metabolites included amino acids, di-, and tri-peptides, glutathione, glutamine, glutamate, and arginine metabolism. The top significant metabolites include 1-Aminopropan-2-ol, ophthalmate, serotonin, cystathionine, and gamma-glutamylglutamic acid. Lung function represented by an above-average FEV1% level was associated with decreased glutamic acid and increased guanosine levels. Conclusion Metabolomic profiling identified alterations in different amino acids and dipeptides, involved in regulating glutathione metabolism. Two metabolites, 3,4-dihydroxymandelate-3-O-sulfate and 5-Aminopentanoic acid, were identified in common between the three anlayses and may represent as highly sensitive biomarkers for CF.This publication has 58 references indexed in Scilit:
- Protective effect of vanillin against carbon tetrachloride (CCl4)-induced oxidative brain injury in ratsToxicology and Industrial Health, 2011
- Metabolomic Profiling Reveals Biochemical Pathways and Biomarkers Associated with Pathogenesis in Cystic Fibrosis CellsOnline Journal of Public Health Informatics, 2010
- Differential 12C-/13C-Isotope Dansylation Labeling and Fast Liquid Chromatography/Mass Spectrometry for Absolute and Relative Quantification of the MetabolomeAnalytical Chemistry, 2009
- Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patientsBiomarkers, 2009
- Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practiceJournal of Cystic Fibrosis, 2008
- CFTR Expression in Human Neutrophils and the Phagolysosomal Chlorination Defect in Cystic FibrosisBiochemistry, 2006
- Mesenteric Organ Production, Hepatic Metabolism, and Renal Elimination of Norepinephrine and Its Metabolites in HumansJournal of Neurochemistry, 1996
- 1‐Piperideine as an In Vivo Precursor of the γ‐Aminobutyric Acid Homologue 5‐Aminopentanoic AcidJournal of Neurochemistry, 1985
- Impaired beta adrenergic receptor binding and function in cystic fibrosis neutrophils.JCI Insight, 1981
- Serotonin metabolism in cystic fibrosis.Archives of Disease in Childhood, 1977